Diet supplements, resveratrol and protocatechuic acid, do not disturb wellness and liver morphology in rats

• Autorzy: Szumilo J. , Fraczek M. , Klepacz R. , Szumilo M. , Burdan F.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to evaluate the influence of a prolonged administration of two natural compounds – resveratrol (20 ppm) and protocatechuic acid (2000 ppm) – on the health status of Wistar rats. The animals were kept on supplemented diets for 7 and 24 weeks. Body weight was assessed weekly, and liver weight during autopsy. Liver morphology was evaluated histologically. The body weight in the 24th week, body weight gain (between the 1st and the 24th week of the experiment), and liver weight were significantly higher for the animals kept on the diet including resveratrol throughout the experiment than for those that had received this diet during the initial 7 weeks. However, differences in these parameters, as well as in the relative liver weight, between the control group and the groups exposed to both compounds were insignificant. Occasionally, mild, mostly reversible, microscopic hepatic changes (i.e., hydropic and fatty changes) were found, and these were slightly more common in the groups kept on supplemented diets. It seems that resveratrol and protocatechuic acid did not significantly disturb the wellness of rats, even after prolonged exposure.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 05
• Opis fizyczny: p.298-302.,fig.,ref.

Twórcy

autor

Szumilo J.

• Department of Clinical Pathomorphology, Medical University of Lublin, Ceramiczna 1, 20-150 Lublin

autor

Fraczek M.

• Department of Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin

autor

Klepacz R.

• Department of Clinical Pathomorphology, Medical University of Lublin, Ceramiczna 1, 20-150 Lublin

autor

Szumilo M.

• Department of Applied Pharmacy, Medical University of Lublin, Chodzki 1, 20-093 Lublin

autor

Burdan F.

• Department of Human Anatomy, Medical University in Lublin, Jaczewskiego 4, 20-090 Lublin

Bibliografia

• 1. Brown V. A., Patel K. R., Viskaduraki M., Crowell J. A., Perloff M., Booth T. D., Vasilinin G., Sen A., Schinas A. M., Piccirilli G., Brown K., Steward W. P.,Gescher A. J., Brenner D. E.: Repeat dose study of the cancer chemopreventiveagent resveratrol in healthy volunteers: safety, pharmacokinetics, and effecton the insulin-like growth factor axis. Cancer Res. 2010, 70, 9003-9011.
• 2. Brzozowska A.: Wzbogacanie żywności i suplementacja diety składnikami odżywczymi – korzyści i zagrożenia. Żywność 2001, 4, 16-28.
• 3. Chan C. C., Lee K. C., Huang Y. H., Chou C. K., Lin H. C., Lee F. Y.: Regulation by resveratrol of the cellular factors mediating liver damage and regenerationafter acute toxic liver injury. J. Gastroenterol. Hepatol. 2014, 29, 603-613.
• 4. Dal-Pan A., Blanc S., Aujard F.: Resveratrol suppresses body mass gain in a seasonal no-human primate model of obesity. BMC Physiol. 2010, 10, 11-20.
• 5. Frączek M., Szumiło J., Podlodowska J., Burdan F.: Resweratrol – fitofenol o wielokierunkowym działaniu. Pol. Merkuriusz Lek. 2012, 32, 143-146.
• 6. Frączek M., Szumiło M., Burdan F., Szumiło J.: Suplementacja diety. Zdr. Publ. 2012, 122, 329-331.
• 7. Juan M. E., Vinardell M. P., Planas J. M.: The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 2002,132, 257-260.
• 8. Keenan K. P., Ballam G. C., Hought D. G., Laroque P.: Nutrition, [in:] Krinke G. J. (red.): The laboratory rat. Academic Press, San Diego 2000.
• 9. Kuroiwa Y., Nishikawa A., Kitamura Y., Kanki K., Ishii Y., Umemura T., Hirose M.: Protective effects of benzyl isothiocyanate and sulforaphane butnot resveratrol against initiation of pancreatic carcinogenesis in hamsters.Cancer Lett. 2006, 241, 275-280.
• 10. Li Z. G., Hong T., Shimada Y., Komoto I., Kawabe A., Ding Y., Kaganoi J., Hashimoto Y., Imamura M.: Suppression of N-nitrosomethylbenzylamine(NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol.Carcinogenesis 2002, 23, 1531-1536.
• 11. Lin H. H., Chen J. H., Wang C. J.: Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne. Curr.Med. Chem. 2011, 18, 1245-1254.
• 12. McDonald R. B.: Some considerations for the development of diets for mature rodents used in long-term investigations. J. Nutr. 1997, 127 (suppl. 5),847S-850S.
• 13. Mieszkowska M., Michota-Kotulska E.: Suplementy diety – korzyści i działania niepożądane. Bezpieczeństwo Pracy 2008, 6, 28-30.
• 14. Nakamura Y., Torikai K., Ohigashi H.: Toxic dose of a simple phenolic antioxidant, protocatechuic acid, attenuates the glutathione level in ICR mouseliver and kidney. J. Agric. Food Chem. 2001, 49, 5674-5678.
• 15. Rocha K. K. R., Souza G. A., Ebaid G. X., Seiva F. R. F., Cataneo A. C., Novelli E. L. B.: Resveratrol toxicity: effects on risk factors of atherosclerosis andhepatic oxidative stress in standard and high-fat diets. Food Chem. Toxicol.2009, 47, 1362-1367.
• 16. Suzuki R., Kohno H., Sugie S., Tanaka T.: Dietary protocatechuic acid during the progression phase exerts chemopreventive effects on chemically induced rat tongue carcinogenesis. Asian Pac. J. Cancer Prev. 2003, 4, 319-326.
• 17. Szumiło J.: Kwas protokatechowy w prewencji nowotworów. Post. Hig. Med. Dosw. 2005, 59, 608-615.
• 18. Szumiło J.: Resweratrol – ocena działania przeciwnowotworowego. Pol. Merkuriusz Lek. 2006, 20, 362-364.
• 19. Tanaka T., Kojima T., Kawamori T., Mori H.: Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer 1995,75, 1433-1439.
• 20. Williams L. D., Burdock G. A., Edwards J. A., Beck M., Bausch J.: Safety studies conducted on high-purity trans-resveratrol in experimental animals.Food Chem. Toxicol. 2009, 47, 2170-2182.
• 21. Young G. S., Kirkland J. B.: Rat models of caloric intake and activity: relationships to animal physiology and human health. Appl. Physiol. Nutr. Metab. 2006, 32, 161-176.